ADMA Biologics promotes Brad Tade to CFO and Treasurer, effective July 24, 2024

ADMA BIOLOGICS, INC.

Brad Tade, former VP Financial Operations, promoted to CFO and Treasurer effective July 24, 2024.
Base salary set at $435,000 annually; target bonus of 45% of base salary.
Granted 115,100 stock options and 72,400 RSUs, each vesting over four years.
Severance includes 12 months base salary; 15 months plus 1.5x target bonus if within one year of change of control.
Tade joined ADMA in June 2023; prior roles at Baxter International and Becton Dickinson.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Role change

Brad Tade

Chief Financial Officer and Treasurer

ADMA · ADMA BIOLOGICS, INC.

Effective: 2024-07-24
Filed: July 26, 2024, 7:59 PM ET

Brad Tade, former Vice President, Financial Operations of ADMA Biologics, Inc. (the "Company"), was promoted to Chief Financial Officer and Treasurer of the Company

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Brad Tade changed role as Chief Financial Officer and Treasurer at ADMA BIOLOGICS, INC..

Action: promoted
Role: Chief Financial Officer and Treasurer

Exact text from the filing

Brad Tade, former Vice President, Financial Operations of ADMA Biologics, Inc. (the "Company"), was promoted to Chief Financial Officer and Treasurer of the Company

View on SEC.gov

ADMA BIOLOGICS, INC. filing history →

Source: SEC EDGAR

accession 0001140361-24-034440

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.